Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

OPGN OpGen Inc

0.0161 (2.68%)
19 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
OpGen Inc OPGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0161 2.68% 0.616 09:00:00
개장가 저가 고가 종가 전일 종가
0.585 0.565 0.6134 0.6161 0.5999
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/03/202405:20APSShares Rip In Reaction To Activist Investor Becoming CEO
26/03/202405:05GLOBEOpGen Announces Acquisition of Preferred Stock by David..
14/02/202406:30EDGAR2Form 8-K - Current report
08/02/202421:30EDGAR2Form 8-K - Current report
10/01/202406:30EDGAR2Form 8-K - Current report
13/12/202306:58EDGAR2Form 8-K - Current report
06/12/202306:37EDGAR2Form 8-K - Current report
24/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
15/11/202306:30GLOBEOpGen Reports Third Quarter 2023 Financial Results and..
14/11/202306:59EDGAR2Form S-3 - Registration statement under Securities Act of..
08/11/202306:30EDGAR2Form 8-K - Current report
27/10/202305:30EDGAR2Form 8-K - Current report
17/10/202305:30EDGAR2Form 8-K - Current report
14/10/202306:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/10/202306:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/10/202306:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/10/202306:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/10/202306:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202301:32GLOBEOpGen Enters Into Warrant Inducement Transaction for up to..
12/10/202305:40EDGAR2Form 8-K - Current report
12/10/202305:30EDGAR2Form 8-K - Current report
29/09/202305:24EDGAR2Form RW - Registration Withdrawal Request
09/09/202305:30EDGAR2Form 8-K - Current report
08/09/202305:30EDGAR2Form 8-K - Current report
14/08/202321:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:31EDGAR2Form 8-K - Current report
11/08/202305:15GLOBEOpGen Reports Second Quarter 2023 Financial Results and..
07/08/202320:30GLOBEOpGen’s Subsidiary Ares Genetics Releases New Features to..
03/08/202321:00GLOBEOpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
03/08/202320:30GLOBEOpGen to Provide Business Update and Financial Results for..
01/08/202322:40EDGAR2Form DEF 14A - Other definitive proxy statements
22/07/202305:55EDGAR2Form PRE 14A - Other preliminary proxy statements
19/07/202320:30GLOBEOpGen’s Subsidiary Curetis Meets Milestones of Extended and..
15/07/202305:30EDGAR2Form S-1 - General form for registration of securities under..
06/07/202305:30EDGAR2Form 8-K - Current report
01/07/202305:30EDGAR2Form 8-K - Current report
26/06/202320:30GLOBEOpGen Subsidiary Ares Genetics Successfully Maintains Key..
22/06/202320:30GLOBEOpGen’s Subsidiary Curetis Receives Batch of Ten New..
20/06/202320:30GLOBEOpGen Presents Unyvero Urinary Tract Infection Panel Trial..
16/05/202305:15GLOBEOpGen Reports First Quarter 2023 Financial Results and..
08/05/202320:30GLOBEOpGen to Provide Business Update and Financial Results for..
05/05/202305:30GLOBEOpGen Announces Closing of $3.5 Million Public Offering
02/05/202310:00GLOBEOpGen Announces Pricing of $3.5 Million Public Offering
27/04/202305:30GLOBEOpGen’s Subsidiary Curetis Meets All Remaining Key..

최근 히스토리

Delayed Upgrade Clock